vimarsana.com

Latest Breaking News On - Celsion corporation - Page 6 : vimarsana.com

Global Nucleic Acid Based Gene Therapy Market Report 2022

Celsion Co (NASDAQ:CLSN) Short Interest Down 22 8% in May

Celsion Co. (NASDAQ:CLSN – Get Rating) was the recipient of a significant decline in short interest in the month of May. As of May 15th, there was short interest totalling 137,400 shares, a decline of 22.8% from the April 30th total of 177,900 shares. Based on an average daily volume of 319,600 shares, the days-to-cover […]

Celsion (CLSN) – Analysts Weekly Ratings Changes

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Celsion (NASDAQ:CLSN) Research Coverage Started at StockNews com

StockNews.com began coverage on shares of Celsion (NASDAQ:CLSN – Get Rating) in a research report issued on Saturday. The firm set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright assumed coverage on shares of Celsion in a research note on Tuesday. They set a “buy” rating and a $16.00 target price on […]

Zacks: Analysts Anticipate Celsion Co (NASDAQ:CLSN) Will Announce Earnings of -$0 94 Per Share

Wall Street analysts predict that Celsion Co. (NASDAQ:CLSN – Get Rating) will report earnings of ($0.94) per share for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Celsion’s earnings, with the lowest EPS estimate coming in at ($1.08) and the highest estimate coming in at ($0.77). Celsion posted earnings per […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.